Physician profile
Jared D Avi
NPI 1417082850
$6,737.50
in general payments reported to CMS, 2019-2025
10 companies · $219 in 2025
The $219 reported for 2025 was more than what 90% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,976 · 2022: $185 · 2023: $31.06 · 2024: $327 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $3,198.24 | 2021 | |
| Baudax Bio INC. | $2,890.06 | 2021-2022 | |
| Neuros Medical, INC. | $194.64 | 2025 | Altius |
| Boston Scientific Corporation | $175.12 | 2022-2025 | Intracept, General - Pain Management |
| Heron Therapeutics, INC. | $156.75 | 2024 | Zynrelef |
| Si-Bone, INC. | $33.51 | 2024 | |
| Relievant Medsystems, INC. | $31.06 | 2023 | Intracept |
| Vertos Medical, INC. | $21.35 | 2024 | Mild Device Kit |
| Medtronic, INC. | $21.26 | 2024 | Propel |
| Abbott Laboratories | $15.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared D Avi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.